$G

Weiner Michael Hal sold $201K of G

Weiner Michael Hal (Chief Financial Officer) sold 5,900 shares of Genpact LTD (G) at $34.04 ($0.20M total) on 2026-08-13.

Original reporting
SEC EDGAR · Weiner Michael Hal
Published Aug 14, 2026, 8:11 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Aug 14, 2026, 8:50 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$G
Neutral
low confidence
Mentioned
$G
Relevance
4/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$GNeutralLow
01

Why it matters

The only new fact is the CFO’s open-market sale details (shares, price, total value, and post-transaction holdings). No guidance, earnings, or corporate event is disclosed.

02

Market read

Traders may note insider selling as a minor sentiment datapoint, but there is no fundamental catalyst in the filing.

03

What to watch

Insider sales do not reveal whether the executive remains bullish long-term; without additional context (other filings, options exercises, or large-scale sales), signal quality is low.

Relevance 4/10Novelty 3/10Timing: filed 2026-08-14, transaction dated 2026-08-13

Background

The article is a SEC Form 4 insider transaction disclosure for Genpact LTD, reported by the CFO.

Company-level read

Ticker impact

$GNeutralLow confidence
Context

Genpact CFO sold 5,900 shares in an open-market transaction on 2026-08-13 at $34.0400, totaling about $200.8K.

Expected impact

Limited near-term impact; any effect is likely sentiment-only and short-lived.

Evidence & confidence

Form 4 insider sales are common and this filing provides no new operational, financial, or regulatory information. The disclosed value is modest and there is no accompanying company-specific catalyst.

Market effects

No clear sector read-through from a single, modest insider sale.

None indicated.

None indicated.

Counterpoint

The absence of a 10b5-1 plan could be interpreted as discretionary selling, but insider sales often reflect diversification or personal liquidity needs.

Key entities

  • Genpact LTD

    Subject of the Form 4 insider transaction disclosure.

  • Weiner Michael Hal

    Genpact CFO who reported the sale.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$GMed

Genpact’s ED NOC Rejection Quashed: Karnataka HC Remands Matter for Fresh Decision on USD 100 Million GIFT City Investment

The Karnataka High Court overturned the Enforcement Directorate's rejection of Genpact's application for a No-Objection Certificate (NOC) for a $100 million investment in GIFT City, stating that ongoing investigations alone do not justify refusal. The court also vacated interim protection against the ED's seizure of Genpact's Gurgaon property. The case involves a 2015 restructuring of Genpact's Indian operations and alleged FEMA violations.

MedAI 8/10

Karnataka High Court upholds ED seizure order against Genpact

The Karnataka High Court upheld an Enforcement Directorate (ED) seizure order against Genpact India under FEMA, while quashing the ED's refusal to grant a no-objection certificate (NOC) for $100 million overseas remittance. The court found the refusal lacked adequate reasons and ordered a fresh decision within 10 days. The ED had accused Genpact of siphoning foreign exchange, but the court did not rule on the merits of the case.

$GMedAI 8/10

Karnataka HC upholds Genpact office seizure in ₹7,800-cr case

The Karnataka High Court upheld the seizure of Genpact India's Gurugram office by the Enforcement Directorate in a ₹7,800-crore money-routing case. The court also directed authorities to reconsider Genpact's $100-million investment proposal in GIFT City. The case involves transactions with Morgan Stanley and Genpact entities.

$GMed

Genpact Q2 Earnings Call Highlights

Genpact (NYSE:G) said it expects more than $1 billion in agentic total contract value in 2026, about 5x 2025. Management reported 3% net revenue growth and 300 bps gross-margin expansion from clients shifting to agentic delivery. Q2 gross margin rose to 36.5%, adjusted operating income was $234M, and adjusted EPS was $1.00. Genpact reaffirmed 2026 revenue growth of at least 7% and guided Q3 revenue to $1.369B-$1.382B.